- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Capping Medicaid Spending, Raising Age for Medicare Among Options Explored in CBO Report
Capping federal Medicaid spending, raising the eligibility age for Medicare, and bundling Medicare payments to healthcare providers are some of the federal spending reduction possibilities included in a report by the Congressional Budget Office released Wednesday.
Capping federal Medicaid spending, raising the eligibility age for Medicare, and bundling Medicare payments to healthcare providers are some of the federal spending reduction possibilities included in a report by the Congressional Budget Office (PDF) released Wednesday.
The release of the 316-page document came the same day the joint House and Senate budget conference committee resumed deliberations on fiscal issues with the goal of reaching a broader agreement on spending and taxes to avoid another government shutdown and threat of debt default. The report was unsolicited by Congress and is meant to inform lawmakers about the budgetary implications of various ways to reduce spending or increase revenues, the budgeting agency said. Non-healthcare related proposals included reducing social security benefits for new beneficiaries by 15%, increasing federal insurance premiums for private pension plans, and reducing or eliminating subsidized loans for undergraduate students.
The government is currently operating under legislation that provides funding until Jan. 15 and suspends the borrowing limit until Feb. 7. CBO Director Douglas Elmendorf testified at the panel and said the report could help lawmakers during their budget deliberations.
Read the full story here: http://bit.ly/1bqHQtT
Source: Modern Healthcare
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More
